Muna Therapeutics Secures $1 Million Alzheimer’s Grant for Innovative MNA-001 Development Muna Therapeutics receives a $1 million grant from the Alzheimer's Association to accelerate the development of MNA-001, a novel therapy aimed at Alzheimer's disease.

Muna Therapeutics Secures $1 Million Alzheimer’s Grant for Innovative MNA-001 Development #Denmark #Copenhagen #Muna_Therapeutics #MNA-001 #Alzheimer's_Grant

Muna Therapeutics Commences Phase 1 Trial for Breakthrough Alzheimer's Treatment Muna Therapeutics has initiated its Phase 1 trial of MNA-001, an innovative treatment aimed at improving outcomes for early Alzheimer's patients. The study focuses on safety, tolerability, and effects on neurodegeneration.

Muna Therapeutics Commences Phase 1 Trial for Breakthrough Alzheimer's Treatment #Denmark #Copenhagen #Muna_Therapeutics #TREM2 #Alzheimer's_Treatment

Muna Therapeutics and GSK Join Forces to Revolutionize Alzheimer's Treatments Muna Therapeutics has partnered with GSK to fast-track Alzheimer's disease research, leveraging innovative techniques to discover new treatments.

Muna Therapeutics and GSK Join Forces to Revolutionize Alzheimer's Treatments #Denmark #Copenhagen #Alzheimer's_Disease #GSK #Muna_Therapeutics